Free Trial

DURECT (DRRX) Stock Price, News & Analysis

DURECT logo
$0.63 -0.01 (-1.73%)
As of 07/11/2025 04:00 PM Eastern

About DURECT Stock (NASDAQ:DRRX)

Key Stats

Today's Range
$0.53
$0.64
50-Day Range
$0.50
$0.73
52-Week Range
$0.48
$1.74
Volume
78,476 shs
Average Volume
38,063 shs
Market Capitalization
$19.42 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Hold

Company Overview

DURECT Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
30th Percentile Overall Score

DRRX MarketRank™: 

DURECT scored higher than 30% of companies evaluated by MarketBeat, and ranked 879th out of 944 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Earnings Growth

    Earnings for DURECT are expected to decrease in the coming year, from ($0.50) to ($0.52) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of DURECT is -4.17, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of DURECT is -4.17, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    DURECT has a P/B Ratio of 2.16. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about DURECT's valuation and earnings.
  • Percentage of Shares Shorted

    2.84% of the float of DURECT has been sold short.
  • Short Interest Ratio / Days to Cover

    DURECT has a short interest ratio ("days to cover") of 7.5.
  • Change versus previous month

    Short interest in DURECT has recently decreased by 2.06%, indicating that investor sentiment is improving.
  • Dividend Yield

    DURECT does not currently pay a dividend.

  • Dividend Growth

    DURECT does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    2.84% of the float of DURECT has been sold short.
  • Short Interest Ratio / Days to Cover

    DURECT has a short interest ratio ("days to cover") of 7.5.
  • Change versus previous month

    Short interest in DURECT has recently decreased by 2.06%, indicating that investor sentiment is improving.
  • News Sentiment

    DURECT has a news sentiment score of 1.87. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 1.00 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for DURECT this week, compared to 0 articles on an average week.
  • Search Interest

    3 people have searched for DRRX on MarketBeat in the last 30 days.
  • MarketBeat Follows

    1 people have added DURECT to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, DURECT insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 3.20% of the stock of DURECT is held by insiders.

  • Percentage Held by Institutions

    Only 28.03% of the stock of DURECT is held by institutions.

  • Read more about DURECT's insider trading history.
Receive DRRX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for DURECT and its competitors with MarketBeat's FREE daily newsletter.

DRRX Stock News Headlines

Oppenheimer Sticks to Its Buy Rating for Durect (DRRX)
Gold is soaring. Here’s how to get paid from it
Gold just broke through $3,300… And while the headlines shout about price targets, something even more powerful is happening behind the scenes… Some investors are using a little-known ETF to collect up to $1,152/month from gold's surge. No trading gold futures. No mining stocks. No vaults. Just a simple fund delivering monthly payouts — like clockwork.
See More Headlines

DRRX Stock Analysis - Frequently Asked Questions

DURECT's stock was trading at $0.75 at the start of the year. Since then, DRRX stock has decreased by 16.6% and is now trading at $0.6257.

DURECT Corporation (NASDAQ:DRRX) issued its quarterly earnings results on Wednesday, March, 26th. The specialty pharmaceutical company reported ($0.06) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.06 by $0.12. The specialty pharmaceutical company had revenue of $2.30 million for the quarter, compared to the consensus estimate of $6.91 million. DURECT had a negative trailing twelve-month return on equity of 267.36% and a negative net margin of 91.54%.
Read the conference call transcript
.

Shares of DURECT reverse split on Tuesday, December 6th 2022.The 1-10 reverse split was announced on Tuesday, December 6th 2022. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, December 6th 2022. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

Shares of DRRX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that DURECT investors own include CymaBay Therapeutics (CBAY), Meta Platforms (META), NVIDIA (NVDA), Advanced Micro Devices (AMD), GE Aerospace (GE), Catalyst Pharmaceuticals (CPRX) and Pfizer (PFE).

Company Calendar

Last Earnings
3/26/2025
Today
7/11/2025
Next Earnings (Estimated)
8/12/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - DRUGS
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:DRRX
CIK
1082038
Employees
80
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($0.15)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$8.32 million
Net Margins
-91.54%
Pretax Margin
-305.34%
Return on Equity
-267.36%
Return on Assets
-64.00%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.23
Quick Ratio
1.22

Sales & Book Value

Annual Sales
$2.03 million
Price / Sales
9.57
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.29 per share
Price / Book
2.16

Miscellaneous

Outstanding Shares
31,040,000
Free Float
30,049,000
Market Cap
$19.42 million
Optionable
Optionable
Beta
0.64
Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

This page (NASDAQ:DRRX) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners